Ovarian Function Suppression Plus Tamoxifen Significantly Reduces Premenopausal Breast Cancer Recurrence Over Tamoxifen and Further Reduction Is Seen When Combined with Exemestane By Ogkologos - July 6, 2026 16 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the SOFT and TEXT studies Source RELATED ARTICLESMORE FROM AUTHOR ESMO Welcomes the WHO Global Status Report on Cancer with Key Recommendations for Equitable Cancer Care Lorlatinib Continues to Show Long-Term Benefit in Newly-Diagnosed Patients with Advanced ALK-positive NSCLC GLP-1 Receptor Agonist Use Associated with a Significantly Lower Short-Term Incidence of Obesity-Associated Cancers Among Obese Individuals Without Diabetes MOST POPULAR EMA Recommends Granting a Marketing Authorisation for the Hybrid Medicine Imatinib July 29, 2021 EMA Recommends Granting a Marketing Authorisation for Tislelizumab August 4, 2023 Reflections from the World Cancer Congress November 30, 2022 Cancer Survivor And His Organ Donor Run NYC Marathon Together To... November 7, 2021 Load more HOT NEWS Efficacy of Romiplostim In the Treatment and Prevention of Recurrence of... Oral Sunvozertinib Prolongs PFS Over Chemotherapy as First-Line Treatment for Patients... Patient Guide in Colorectal Cancer Now Available in Bulgarian Diagnosed With Breast Cancer At 24, Her Biggest Fear Wasn’t Death...
